You reviewed ....
for this content
out of 5
Hospital La Timone of Marseille,
Acute Coronary Syndromes, Interventional Cardiology
All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.
ESC Congress 2019
New strategies in STEMI and cardiogenic shock.
ESC Congress 2018
Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome
Should pharmacotherapy differ?
ESC Congress 2014
STEMI: essential questions in primary PCI.
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (Predictor Of Bleedings with Antiplatelet drugs)
ESC Congress 2013
Impact of dual non-responsiveness to aspirin and clopidogrel on clinical outcomes in patients treated with drug-eluting stents in the ARCTIC study.
Impact of obesity on response to thienopyridine and bleeding risk in patients treated after acute coronary syndrome by clopidogrel or prasugrel
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease